Back to 
NATIONAL BANK OF CANADA /FI/
NATIONAL BANK OF CANADA /FI/
EIGRShowing 0 of 10 quarters
Position history for NATIONAL BANK OF CANADA /FI/'s holdings in EIGER BIOPHARMACEUTICALS INC
As of its Q4 2023 13F, National Bank of Canada held 1,280 shares of EIGR (Eiger Biopharmaceuticals), worth $301. National Bank of Canada's 13F filings listed EIGR from Q4 2021 to Q4 2023, 9 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of EIGR: AMERIPRISE FINANCIAL INC